David M. Dugan

Jun 12, 2024 | feeds.feedblitz.com | David M. Dugan |Maria Dinzeo |Charles Toutant |Chris O'Malley

Marijuana has been classified as a Schedule I drug since Congress enacted the Controlled Substances Act (CSA) in 1970. Under the CSA, Schedule I drugs are deemed to have a high potential for abuse and have no accepted medical use. For perspective, other drugs listed as a Schedule I drug include, but are not limited to, heroin, lysergic acid diethylamide (LSD) and ecstasy.

May 17, 2024 | law.com | David M. Dugan

Last year, I had the privilege of teaching a Professional Responsibility class of 18 highly talented students from Beijing at an excellent law school. The class started at 8 a.m. and was a hybrid of about 50% in-person and 50% remote attendees from Beijing (twelve hours ahead). I entered the experience excited and left feeling that it had exceeded my already high expectations.

Jan 12, 2024 | feeds.feedblitz.com | David M. Dugan |Colleen Murphy

A recent unpublished Appellate Division opinion provides a useful reminder of the relationship between the corporate veil and the attorney-client privilege. In Royzenshteyn v. Pathak, the shareholders of a closely held corporation decided to raise capital for the business by selling a majority interest, while retaining a minority interest and executive positions under employment contracts.

Jun 2, 2023 | law.com | David M. Dugan

From Data to Decisions Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends. Exclusive Depth and Reach. Law.com Compass includes access to our exclusive industry reports, combining the unmatched expertise of our analyst team with ALM’s deep bench of proprietary information to provide insights that can’t be found anywhere else.